Literature DB >> 15353308

The role of isoflavones in cancer chemoprevention.

Fazlul H Sarkar1, Yiwei Li.   

Abstract

Cancer is one of the major health problems around the world. However, it has been estimated that more than two-thirds of human cancers could be prevented by modification of lifestyle including dietary modification.The incidences of hormone-related cancers are much higher in Western countries compared to Asian countries. One of the major differences in diet between these populations is that the Asians consume a traditional diet high in isoflavones. Epidemiologic evidence together with data from animal and in vitro studies strongly supports relationship between isoflavones and the lower risk of cancers. Isoflavones have been shown to inhibit carcinogenesis in vivo in animal experiments. It has been known that genistein, one of the major isoflavones, inhibits the growth of various cancer cells through the modulation of genes that are related to the control of cell cycle, apoptosis, and cell signaling pathways. Moreover, genistein has been found to be a potent inhibitor of oxidative stress, angiogenesis, and metastasis.Therefore, isoflavones exert beneficial effects on human health and may be promising agents for cancer prevention and/or treatment. However, further in depth experimental investigations along with clinical trials are needed to fully evaluate the value of isoflavones in human cancer prevention and/or treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353308     DOI: 10.2741/1430

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  32 in total

1.  Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Authors:  Iftekhar U Ahmad; Jeffrey D Forman; Fazlul H Sarkar; Gilda G Hillman; Elisabeth Heath; Ulka Vaishampayan; Michael L Cher; Fundagul Andic; Peter J Rossi; Omer Kucuk
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies.

Authors:  Wan-Shui Yang; Puthiery Va; Man-Yu Wong; Huan-Ling Zhang; Yong-Bing Xiang
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

3.  Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Haiyan Xu; Baojian Wu; Kaustubh Kulkarni; Rashim Singh; Lan Tang; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2010-03-16       Impact factor: 3.935

4.  FoxM1 is a novel target of a natural agent in pancreatic cancer.

Authors:  Zhiwei Wang; Aamir Ahmad; Sanjeev Banerjee; Asfar Azmi; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 5.  Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Naghma Khan; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

6.  Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer.

Authors:  Rebecca W Knackstedt; Vondina R Moseley; Michael J Wargovich
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

7.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

Review 8.  Structure, function, and engineering of enzymes in isoflavonoid biosynthesis.

Authors:  Xiaoqiang Wang
Journal:  Funct Integr Genomics       Date:  2010-10-30       Impact factor: 3.410

9.  FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Jiawei Du; Keping Xie
Journal:  Biochim Biophys Acta       Date:  2014-01-11

Review 10.  Inhibition of cancer cell invasion and metastasis by genistein.

Authors:  Janet M Pavese; Rebecca L Farmer; Raymond C Bergan
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.